1:31 PM
 | 
Nov 10, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Intellia raises $150M in follow-on

On Nov. 1, CRISPR company Intellia Therapeutics Inc. (NASDAQ:NTLA) raised $150 million through the sale of 6.3 million shares...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >